[1]
|
Chen, T., Gao, Y., Zhang, S., Wang, Y., Sui, C. and Yang, L. (2023) Methylmalonic Acidemia: Neurodevelopment and Neuroimaging. Frontiers in Neuroscience, 17, Article 1110942. https://doi.org/10.3389/fnins.2023.1110942
|
[2]
|
Han, L.S., Huang, Z., Han, F., Ye, J., Qiu, W.J., Zhang, H.W., Wang, Y., Gong, Z.W. and Gu, X.F. (2015) Clinical Features and MUT Gene Mutation Spectrum in Chinese Patients with Isolated Methylmalonic Acidemia: Identification of Ten Novel Allelic Variants. World Journal of Pediatrics, 11, 358-365. https://doi.org/10.1007/s12519-015-0043-1
|
[3]
|
Thompson, G.N., Christodoulou, J. and Danks, D.M. (1989) Metabolic Stroke in Methylmalonic Acidemia. The Journal of Pediatrics, 115, 499-500. https://doi.org/10.1016/S0022-3476(89)80867-4
|
[4]
|
Zhou, X., Cui, Y. and Han, J. (2018) Methylmalonic Acidemia: Current Status and Research Priorities. Intractable & Rare Diseases Research, 7, 73-78. https://doi.org/10.5582/irdr.2018.01026
|
[5]
|
Fischer, S., Huemer, M., Baumgartner, M., Deodato, F., Ballhausen, D., Boneh, A., Burlina, A.B., Cerone, R., Garcia, P., Gökçay, G., Grünewald, S., Häberle, J., Jaeken, J., Ketteridge, D., Lindner, M., Mandel, H., Martinelli, D., Martins, E.G., Schwab, K.O., Gruenert, S.C., Schwahn, B.C., Sztriha, L., Tomaske, M., Trefz, F., Vilarinho, L., Rosenblatt, D.S., Fowler, B. and Dionisi-Vici, C. (2014) Clinical Presentation and Outcome in a Series of 88 Patients with the cblC Defect. Journal of Inherited Metabolic Disease, 37, 831-840. https://doi.org/10.1007/s10545-014-9687-6
|
[6]
|
Wang, X., Sun, W., Yang, Y., Jia, J. and Li, C. (2012) A Clinical and Gene Analysis of Late-Onset Combined Methylmalonic Aciduria and Homocystinuria, cblC Type, in China. Journal of the Neurological Sciences, 318, 155-159. https://doi.org/10.1016/j.jns.2012.04.012
|
[7]
|
Forny, P., Schnellmann, A.S., Buerer, C., Lutz, S., Fowler, B., Froese, D.S. and Baumgartner, M.R. (2016) Molecular Genetic Characterization of 151 Mut-Type Methylmalonic Aciduria Patients and Identification of 41 Novel Mutations in MUT. Human Mutation, 37, 745-754. https://doi.org/10.1002/humu.23013
|
[8]
|
de Keyzer, Y., Valayannopoulos, V., Benoist, J.F., Batteux, F., Lacaille, F., Hubert, L., Chrétien, D., Chadefeaux-Vekemans, B., Niaudet, P., Touati, G., Munnich, A. and de Lonlay, P. (2009) Multiple OXPHOS Deficiency in the Liver, Kidney, Heart, and Skeletal Muscle of Patients with Methylmalonic Aciduria and Propionic Aciduria. Pediatric Research, 66, 91-95. https://doi.org/10.1203/PDR.0b013e3181a7c270
|
[9]
|
Worgan, L.C., Niles, K., Tirone, J.C., Hofmann, A., Verner, A., Sammak, A., Kucic, T., Lepage, P. and Rosenblatt, D.S. (2006) Spectrum of Mutations in Mut Methylmalonic Acidemia and Identification of a Common Hispanic Mutation and Haplotype. Human Mutation, 27, 31-43. https://doi.org/10.1002/humu.20258
|
[10]
|
Zhang, Y., Song, J.Q., Liu, P., Yan, R., Dong, J.H., Yang, Y.L., Wang, L.F., Jiang, Y.W., Zhang, Y.H., Qin, J. and Wu, X.R. (2007) Clinical Studies on Fifty-Seven Chinese Patients with Combined Methylmalonic Aciduria and Homocysteinemia. Zhonghua Er Ke Za Zhi, 45, 513-517.
|
[11]
|
Carrillo-Carrasco, N., Chandler, R.J. and Venditti, C.P. (2012) Combined Methylmalonic Acidemia and Homocystinuria, cblC Type. I. Clinical Presentations, Diagnosis and Management. Journal of Inherited Metabolic Disease, 35, 91-102. https://doi.org/10.1007/s10545-011-9364-y
|
[12]
|
Forny, P., Hörster, F., Ballhausen, D., Chakrapani, A., Chapman, K.A., Dionisi-Vici, C., Dixon, M., Grünert, S.C., Grunewald, S., Haliloglu, G., Hochuli, M., Honzik, T., Karall, D., Martinelli, D., Molema, F., Sass, J.O., Scholl-Bürgi, S., Tal, G., Williams, M., Huemer, M. and Baumgartner, M.R. (2021) Guidelines for the Diagnosis and Management of Methylmalonic Acidaemia and Propionic Acidaemia: First Revision. Journal of Inherited Metabolic Disease, 44, 566-592. https://doi.org/10.1002/jimd.12370
|
[13]
|
Hörster, F., Baumgartner, M.R., Viardot, C., Suormala, T., Burgard, P., Fowler, B., Hoffmann, G.F., Garbade, S.F., Kölker, S. and Baumgartner, E.R. (2007) Long-Term Outcome in Methylmalonic Acidurias Is Influenced by the Underlying Defect (mut0, mut-, cblA, cblB). Pediatric Research, 62, 225-230. https://doi.org/10.1203/PDR.0b013e3180a0325f
|
[14]
|
Zwickler, T., Lindner, M., Aydin, H.I., Baumgartner, M.R., Bodamer, O.A., Burlina, A.B., Das, A.M., DeKlerk, J.B., Gökcay, G., Grünewald, S., Guffon, N., Maier, E.M., Morava, E., Geb, S., Schwahn, B., Walter, J.H., Wendel, U., Wijburg, F.A., Müller, E., Kölker, S., Hörster, F. (2008) Diagnostic Work-Up and Management of Patients with Isolated Methylmalonic Acidurias in European Metabolic Centres. Journal of Inherited Metabolic Disease, 31, 361-367. https://doi.org/10.1007/s10545-008-0804-2
|
[15]
|
Ktena, Y.P., Paul, S.M., Hauser, N.S., Sloan, J.L., Gropman, A., Manoli, I. and Venditti, C.P. (2015) Delineating the Spectrum of Impairments, Disabilities, and Rehabilitation Needs in Methylmalonic Acidemia (MMA). American Journal of Medical Genetics Part A, 167, 2075-2084. https://doi.org/10.1002/ajmg.a.37127
|
[16]
|
Nizon, M., Ottolenghi, C., Valayannopoulos, V., Arnoux, J.B., Barbier, V., Habarou, F., Desguerre, I., Boddaert, N., Bonnefont, J.P., Acquaviva, C., Benoist, J.F., Rabier, D., Touati ,G. and de Lonlay, P. (2013) Long-Term Neurological Outcome of a Cohort of 80 Patients with Classical Organic Acidurias. Orphanet Journal of Rare Diseases, 8, Article No. 148. https://doi.org/10.1186/1750-1172-8-148
|
[17]
|
Cosson, M.A., Benoist, J.F., Touati, G., Déchaux, M., Royer, N., Grandin, L., Jais, J.P., Boddaert, N., Barbier, V., Desguerre, I., Campeau, P.M., Rabier, D., Valayannopoulos, V., Niaudet, P. and de Lonlay, P. (2009) Long-Term Outcome in Methylmalonic Aciduria: A Series of 30 French Patients. Molecular Genetics and Metabolism, 97, 172-178. https://doi.org/10.1016/j.ymgme.2009.03.006
|
[18]
|
Kruszka, P.S., Manoli, I., Sloan, J.L., Kopp, J.B. and Venditti, C.P. (2013) Renal Growth in Isolated Methylmalonic Acidemia. Genetics in Medicine, 15, 990-996. https://doi.org/10.1038/gim.2013.42
|